NewGen Provides Update on K25.ai Investment and Strengthened Financial Position
Rhea-AI Summary
NewGen (Nasdaq: NIVF) reported that its agreed 13% stake in K25.ai, based on K25.ai’s recently closed Series A round implying a US$200 million valuation, is now valued at approximately US$26 million, representing an expected unrealized gain of about US$8.5 million, subject to completion of the related share purchase agreements.
According to NewGen, this appreciation further strengthens its 2026 financial position following net profit of US$9.9 million for the year ended December 31, 2025 and net assets of about US$25.98 million at that date. The company also expects its total outstanding Class A ordinary shares to reach roughly 5.9 million after completing the issuance of 2,500,000 new shares announced on July 27, 2026.
Positive
- Net profit US$9.9 million for fiscal year 2025
- Net assets ~US$25.98 million as of December 31, 2025
- K25.ai stake implied value US$26 million at 13% ownership
- Expected unrealized gain from K25.ai investment of about US$8.5 million
- Investment in K25.ai implied valuation increased to US$200 million
Negative
- New share issuance of 2,500,000 Class A shares increases total to ~5,900,000
- K25.ai stake value and ~US$8.5 million gain remain unrealized and subject to completion
Details
News Market Reaction – NIVF
In the Jul 30 session, NIVF declined 0.46%, reflecting a mild negative market reaction. Argus tracked a peak move of +19.8% during that session. Argus tracked a trough of -30.7% from its starting point during tracking. Our momentum scanner triggered 38 alerts that day, indicating elevated trading interest and price volatility. Trading volume was very high at 3.2x the daily average, suggesting heavy selling pressure.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Net profit
- US$9.9 million
- Fiscal year ended December 31, 2025
- Net assets
- US$25.98 million
- As of December 31, 2025
- K25.ai implied valuation
- US$200 million
- Current implied valuation
- K25.ai stake
- 13%
- NewGen's agreed stake
- Stake valuation
- US$26 million
- Based on K25.ai's implied valuation
- Unrealized gain
- US$8.5 million
- Expected gain on the K25.ai stake
- Share issuance
- 2,500,000 Class A ordinary shares
- Issuance announced July 27, 2026
- Expected shares outstanding
- 5,900,000 Class A ordinary shares
- Following completion of the issuance
Previous AI Reports
-
K25.ai Series A valuation reached US$200 million, implying value uplift for NewGen's stake.
-
K25.ai closed a Series A round with strategic support from Amber Group.
-
NewGen completed its US$10 million K25.ai commitment and expected ownership increase.
-
K25.ai announced further strategic investment from NewGen at a US$100 million valuation.
-
NewGen increased its K25.ai stake and adopted a digital asset treasury strategy.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
unrealized gain financial
implied valuation financial
series a investment round financial
market capitalization financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
NewGen’s total shares outstanding count expected to reach 5.9 million following recently announced share issuance, bolstering market capitalization
NewGen’s agreed
BANGKOK, July 30, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (Nasdaq: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today provided an update on its strategic investment in K25.ai and the related impact on the Company’s capitalization and financial position.
NewGen reported net profit attributable to shareholders of US
Based on a current implied valuation of US
Upon completion of the issuance of 2,500,000 Class A ordinary shares as announced on July 27, 2026, NewGen’s total outstanding Class A ordinary share count is expected to reach approximately 5,900,000.
Alfred Siu, Founder, Chairman and CEO of NewGen, commented, “Our 2025 results, including US
About NewGen
NewGenIVF Group Limited is a technology-forward, diversified growth company pursuing opportunities across real estate development, digital asset innovation, and reproductive health solutions. The Company operates through NewGenProperty, focused on real estate development projects in Ras Al Khaimah, United Arab Emirates; NewGenDigital, focused on digital asset and decentralized-finance solutions; and NewGenSup, focused on health and longevity products and solutions. NewGenIVF’s legacy business includes IVF and assisted reproductive treatment services across Asia. To learn more, visit www.nivf.global. Information contained on, or accessible through, the Company’s website is not incorporated by reference into this press release.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include, but are not limited to, statements regarding: the expected completion of NewGen's acquisitions of equity interests in K25.ai and the resulting aggregate ownership of
These forward-looking statements are based on the Company's current expectations, estimates, projections and assumptions as of the date of this press release and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to differ materially from those expressed or implied. These risks and uncertainties include, among others: the risk that the acquisitions of equity stakes in K25.ai are not completed on the terms described or at all; the risk that the carrying value of the Company's investment in K25.ai is not realized and may be impaired; and share dilution and capital markets issuance risk. Additional risks are described in the Company's Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission.
All information provided in this press release is as of the date of this press release. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable securities laws.
Contacts
ICR, LLC
Robin Yang
Phone: +1 (212) 537-3847
Email: Newgenivf.IR@icrinc.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.